| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049595 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; osteoporosis |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048390 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048305 CD147 binding molecules as therapeutics |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070044795 Method and apparatus for dispensing inhalator medicament |
| 03/01/2007 | DE20122679U1 Behandlung von Knochenerkrankungen Treatment of bone diseases |
| 03/01/2007 | DE102005040429A1 Wirkstofffreisetzungssystem und seine Verwendung The drug delivery system and its use |
| 03/01/2007 | CA2620106A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620032A1 Polymer conjugates of k-252a and derivatives thereof |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2619365A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | CA2606879A1 Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof |
| 02/28/2007 | EP1757944A1 A method of determining the initial dose of vitamin D compounds |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757610A1 Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 02/28/2007 | EP1757606A1 Xanthinderivatives, preparation thereof and their use as medical agents |
| 02/28/2007 | EP1757602A1 Vla-4 inhibitor |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757296A1 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation |
| 02/28/2007 | EP1757291A2 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-YL)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof |
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | EP1757272A2 Drug-release system and its use |
| 02/28/2007 | EP1756151A1 Osteoblast growth factor |
| 02/28/2007 | EP1756106A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/28/2007 | EP1756041A2 Polycationic compounds and uses thereof |
| 02/28/2007 | EP1755681A2 Combination of organic compounds |
| 02/28/2007 | EP1755643A2 Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| 02/28/2007 | EP1755637A1 Methods for preventing or treating bone disorders |
| 02/28/2007 | EP1755620A2 Sulphated depolymerised exopolysaccharide derivatives, their preparation and uses |
| 02/28/2007 | EP1755603A2 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity |
| 02/28/2007 | EP1572179B1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1320541B1 Tgf-beta inhibitors and methods |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | EP1029035B1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells |
| 02/28/2007 | EP1025077B1 Novel aryloxy-alkyl-dialkylamines |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921907A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 02/28/2007 | CN1921886A Methods of modulating cytokine activity, related reagents |
| 02/28/2007 | CN1921866A Therapy using a combination of raloxifene and alendronate |
| 02/28/2007 | CN1921859A Indole derivatives for the treatment of bone diseases |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |
| 02/28/2007 | CN1921841A Amines and amides for the treatment of diseases |
| 02/28/2007 | CN1919327A Jinwu Gutong tablet and its preparing method |
| 02/28/2007 | CN1919324A Medicinal liquor for bone health |
| 02/28/2007 | CN1919310A Application of Dendrobium nobile in the preparing process of bone disease treating medicine |
| 02/28/2007 | CN1919278A Blood activating oil and its preparation method |
| 02/28/2007 | CN1919217A Capsule made of ant extract, spirulina platensis dry powder and chinese caterpillar fungus extract |
| 02/28/2007 | CN1919200A Method for inhibiting bone resorption |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301987C 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301734C Oral medication for bones injuries of neck |
| 02/28/2007 | CN1301728C Chinese medicine compound preparation for treating osteoarthropathy and its preparation method |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/28/2007 | CN1301709C Skin plaster containing aceclofenac |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183280 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |
| 02/27/2007 | US7182960 Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone |
| 02/22/2007 | WO2007021710A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 02/22/2007 | WO2007020075A1 Use of neuropilin-2 antagonists |
| 02/22/2007 | WO2007002764A3 Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
| 02/22/2007 | WO2006123279A3 Natural drugs containing calcium and phosphate and apparatus for iontophoretic treatment of osteoporosis |
| 02/22/2007 | WO2003073991A3 Methods to increase or decrease bone density |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
| 02/22/2007 | US20070043049 Substituted heterocyclic diarylamine analogues |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070042992 Inulin products with improved nutritional properties |
| 02/22/2007 | US20070042978 Nf-hev compositions and methods of use |